412 related articles for article (PubMed ID: 36998425)
1. Role of noncoding RNAs in liver fibrosis.
Li QY; Gong T; Huang YK; Kang L; Warner CA; Xie H; Chen LM; Duan XQ
World J Gastroenterol; 2023 Mar; 29(9):1446-1459. PubMed ID: 36998425
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.
Ferro A; Saccu G; Mattivi S; Gaido A; Herrera Sanchez MB; Haque S; Silengo L; Altruda F; Durazzo M; Fagoonee S
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540698
[TBL] [Abstract][Full Text] [Related]
3. Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis.
Teng KY; Ghoshal K
Gene Expr; 2015; 16(4):155-62. PubMed ID: 26637395
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNA Associated Competitive Endogenous RNA Regulatory Network: Novel Therapeutic Approach in Liver Fibrosis.
Riaz F; Li D
Curr Gene Ther; 2019; 19(5):305-317. PubMed ID: 31696817
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.
Zhou LY; Lin SN; Rieder F; Chen MH; Zhang SH; Mao R
Inflamm Bowel Dis; 2021 Jun; 27(7):971-982. PubMed ID: 33324986
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of exosome-derived noncoding RNAs in liver.
Zhou ZW; Zheng W; Xiang Z; Ye CS; Yin QQ; Wang SH; Xu CA; Wu WH; Hui TC; Wu QQ; Zhao LY; Pan HY; Xu KY
Lab Invest; 2022 May; 102(5):464-473. PubMed ID: 35013531
[TBL] [Abstract][Full Text] [Related]
8. Whole-transcriptome sequencing revealed differentially expressed mRNAs and non-coding RNAs played crucial roles in NiONPs-induced liver fibrosis.
Li K; Zheng J; Liu H; Gao Q; Yang M; Tang J; Wang H; Li S; Sun Y; Chang X
Ecotoxicol Environ Saf; 2022 Dec; 248():114308. PubMed ID: 36410144
[TBL] [Abstract][Full Text] [Related]
9. New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA-miRNA interactions.
Bian EB; Xiong ZG; Li J
J Cell Physiol; 2019 Mar; 234(3):2194-2203. PubMed ID: 30229908
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis in Cancer Progression: Role of Noncoding RNAs.
Zuo YB; Zhang YF; Zhang R; Tian JW; Lv XB; Li R; Li SP; Cheng MD; Shan J; Zhao Z; Xin H
Int J Biol Sci; 2022; 18(5):1829-1843. PubMed ID: 35342359
[TBL] [Abstract][Full Text] [Related]
11. Non-coding RNA-mediated epigenetic regulation of liver fibrosis.
Yang JJ; Tao H; Deng ZY; Lu C; Li J
Metabolism; 2015 Nov; 64(11):1386-94. PubMed ID: 26362725
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of non-coding RNAs in the Wnt/β-catenin signaling pathway in Prostate Cancer.
Kazmi I; Altamimi ASA; Afzal M; Majami AA; AlGhamdi AS; Alkinani KB; Abbasi FA; Almalki WH; Alzera SI; Kukreti N; Fuloria NK; Sekar M; Abida
Pathol Res Pract; 2024 Feb; 254():155134. PubMed ID: 38277746
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer.
Mohan S; Hakami MA; Dailah HG; Khalid A; Najmi A; Zoghebi K; Halawi MA
Pathol Res Pract; 2024 Jan; 253():155016. PubMed ID: 38070221
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA MBI‑52 inhibits the development of liver fibrosis by regulating the microRNA‑466g/SMAD4 signaling pathway.
Li Y; Liu P; Wei F
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34850963
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
[TBL] [Abstract][Full Text] [Related]
17. Roles of noncoding RNAs in septic acute kidney injury.
Yue L; Gu Y; Xu J; Liu T
Biomed Pharmacother; 2023 Sep; 165():115269. PubMed ID: 37541179
[TBL] [Abstract][Full Text] [Related]
18. Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017-2022).
Wang M; Li Q; Jin M; Wang Z; Zhang X; Sun X; Luo Y
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551201
[TBL] [Abstract][Full Text] [Related]
19. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
[TBL] [Abstract][Full Text] [Related]
20. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
Shao Z; Gao D; Chen L; Ding W; Yu Q
Oncol Rep; 2020 Oct; 44(4):1314-1321. PubMed ID: 32945460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]